| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |